Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Identify the credit cards that offer rewards without annual fees. Enjoy benefits without the financial strain.
27,064 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Crypto prediction markets are growing as traders bet on real-world outcomes. The space blends crypto tech with real e...
As quantum technology moves from labs to real-world use, a single stock could unlock big gains. This article explains...
Bitcoin slumped about 7% on Tuesday as U.S.-Iran tensions mounted, highlighting how macro risk can override crypto sa...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
Three AI infrastructure names join the S&P 500 in a quarterly rebalance, signaling AI hardware is moving from specula...
Trump acknowledges a philosophical difference with his VP on Iran, while markets react to the evolving policy landsca...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
As quantum ‘q-day’ jumps 2029 approaches, Ethereum confronts a growing decision: how to secure old wallets while expa...